Cellect Biotechnology

$1.94
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.

-$0.03 (-1.57%) Today

+$0.06 (+3.19%) As of 1:00 AM UTC after-hours

Why Robinhood?

You can buy or sell APOP and other stocks, options, and ETFs commission-free!

About APOP

Cellect Biotechnology Ltd. engages in the provision of regenerative medicine. Its activities include development of regenerative medicine through the development of products facilitating immune stem cell selection. The company also develops innovative technology, which allows the default stem cells by dramatically reducing of complications existing in conventional selection methods. The company was founded by Kasbian Nuriel Chirich, Shai Yarkoni, and Nadir Askenasy on August 4, 1986 and is headquartered in Kfar Saba, Israel. The listed name for APOP is Cellect Biotechnology Ltd. American Depositary Shares.

CEO

Shai Yarkoni

Employees

Headquarters

Kfar Saba, Jerusalem

Founded

1986

Market Cap

7.35M

Price-Earnings Ratio

—

Dividend Yield

—

Average Volume

64.77K

High Today

$1.96

Low Today

$1.87

Open Price

$1.88

Volume

37.64K

52 Week High

$6.89

52 Week Low

$0.40

Collections

APOP Earnings

-$0.16

-$0.11

-$0.05

$0.00

Q4 FY18

Q1 FY19

Q2 FY19

Q3 FY19

Q4 FY19

Q1 FY20

Q2 FY20

Q3 FY20

Estimated

— per share

Actual

-$0.001 per share